Nitin Agarwal

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Nitin Agarwal sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials 2 currently recruiting upper half by trial count

Nitin Agarwal: 2 sponsored US clinical trials, 2 recruiting.

Nitin Agarwal sponsors 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. The most-studied condition in this pipeline is Herniated Disc, with 1 trials.

Mid-pack sponsor footprint

Nitin Agarwal is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

2 total, page 1 of 1

RECRUITING

Adult Patient Outcomes After Spine Surgery With Fibergraft BG Putty/Viper Prime

NCT06704906
RECRUITING

Conduit Cages and Fibergraft BG Putty

NCT06704919

Therapeutic Areas

Herniated Disc 1
Degeneration of Lumbar Intervertebral Disc 1
Spinal Trauma With Neurological Deficit 1
Spondylolisthesis, Lumbar Region 1
Degenerative Disc Disease 1

What is open in the Nitin Agarwal pipeline

2 recruiting of 2 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Herniated Disc (1 trial), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Nitin Agarwal: open-pipeline peers nationwide

Peers matched on 2 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Nitin Agarwal sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1.522.533.544.5 0%50%100%150% Total trials Recruiting share Nitin Agarwal1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Nitin Agarwal sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Nitin Agarwal sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Nitin Agarwal page

2 registered trials is a research-attention snapshot, not an endorsement of Nitin Agarwal or any single study.

  • 2 of Nitin Agarwal's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Herniated Disc is the condition Nitin Agarwal studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Herniated Disc trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Nitin Agarwal pipeline card: 2 registered trials from official public datasets.Report a data error.